Buscar resultados de ensayos clínicos

Patrocinado por

Leukemia, Prolymphocytic - 23 Studies Found

Estado Estudiar
Completed Nombre del estudio: Combined Immunochemotherapy in Patients With T-Prolymphocytic Leukemia (T-PLL)
Condición: T-cell-prolymphocytic Leukemia
Fecha: 2010-08-20
Intervenciones:
  • Drug: Fludarabine, Mitoxantrone, Cyclophosphamide and Alemtuzumab

Terminated Nombre del estudio: Fludarabine, Cyclophosphamide, and Rituximab in Treating Patients With Prolymphocytic Leukemia
Condición: Prolymphocytic Leukemia
Fecha: 2006-01-24
Intervenciones:
  • Biological: rituximab
  • Drug: cyclophosphami
Completed Nombre del estudio: Combination Chemotherapy Followed By Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia
Condición: Prolymphocytic Leukemia
Fecha: 2006-01-16
Intervenciones:
  • Biological: alemtuzumab
  • Drug: cyclophospha
Terminated Nombre del estudio: Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia
Condición:
  • B-cell Chronic Lymphocytic Leukemia
  • Prolymphocytic Leukemia Fecha: 2004-12-07
    Intervenciones: Drug: alvocidib Other Names:
    • FLAVO
    • flavopiridol
    • HMR 1
Completed Nombre del estudio: Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL)
Condición:
  • B-cell Chronic Lymphocytic Leukemia
  • Hematopoietic/Lymphoid Cancer
  • Drug: carfilzomib Given IV inf
Terminated Nombre del estudio: A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Participants With Chronic Leukemia
Condición:
  • Leukemia, Lymphoma, Chronic Lymphocytic
  • Leukemia, Prolymphocytic Fecha: 2007-12-21
    Intervenciones:
    • Drug: CAT-8015 5 mcg/kg Partic
Terminated Nombre del estudio: 17-N-Allylamino-17-Demethoxygeldanamycin With or Without Rituximab in Treating Patients With Relapsed B-Cell Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia
Condición:
  • B-cell Chronic Lymphocytic Leukemia
  • Prolymphocytic Leukemia Fecha: 2004-12-07
    Intervenciones:
    • Drug: tanespimycin Given IV
Withdrawn Nombre del estudio: Phase II Study of VELCADE for Relapsed or Refractory T-cell Prolymphocytic Leukemia
Condición:
  • Leukemia
  • Acute Lymphocytic Leukemia

Fecha: 2010-07-12
Intervenciones: Drug: Velcade IV Other Name: Bortezomib
Completed Nombre del estudio: Alvocidib in Patients With Previously Treated Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia Arising From Chronic Lymphocytic Leukemia (CLL)
Condición: Leukemia, Lymphocytic, Chronic
Fecha: 2007-04-20
Intervenciones: Drug: alvocidib 1st dose: 30 mg/m2 as a 30-minute intraven
Withdrawn Nombre del estudio: Sotrastaurin Acetate in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia, Prolymphocytic Leukemia, or Richter's Transformation
Condición:
  • Prolymphocytic Leukemia
  • Recurrent Mantle Cell Lymphoma
    • Fecha: 2014-11-04
    Intervenciones:
    • Drug: sotrastaurin acetate Giv
Next >>>